The Neuroethics of Pleasure and Addiction in Public Health Strategies Moving Beyond Harm Reduction: Funding the Creation of Non-Addictive Drugs and Taxonomies of Pleasure
Neuroethics 4 (2):103-117 (2010)
AbstractWe are unlikely to stop seeking pleasure, as this would prejudice our health and well-being. Yet many psychoactive substances providing pleasure are outlawed as illicit recreational drugs, despite the fact that only some of them are addictive to some people. Efforts to redress their prohibition, or to reform legislation so that penalties are proportionate to harm have largely failed. Yet, if choices over seeking pleasure are ethical insofar as they avoid harm to oneself or others, public health strategies should foster ethical choice by moving beyond current risk management practices embodied in the harm reduction movement. The neuroscience of pleasure has much to offer neuroethics and public health strategies. Distinguishing between ‘wanting’ and ‘liking’ fosters new understandings of addiction. These hold promise for directing the search for pharmacotherapies which prevent addiction and relapse or disrupt associated neuromechanisms. They could inform new research into creating lawful psychoactive substances which give us pleasure without provoking addiction. As the health and well being of human and other animals rests upon the experience of pleasure, this would be an ethical objective within public health strategy. Were ethical and neurobiological obstacles to ending addiction to be overcome, problems associated with excessive consumption, the lure of unlawful psychoactive substances and the paucity of lawful means to achieve pleasurable altered states would remain. Non-addictive designer drugs, which reliably provided lawful access to pleasures and altered states, would ameliorate these public health concerns insofar as they fostered citizens’ informed, ethical choices according to a neurobiological taxonomy of pleasures
Similar books and articles
Untreated Addiction Imposes an Ethical Bar to Recruiting Addicts for Non-Therapeutic Studies of Addictive Drugs.Peter J. Cohen - 2002 - Journal of Law, Medicine and Ethics 30 (1):73-81.
Psychedelic, Psychoactive, and Addictive Drugs and States of Consciousness.Ralph Metzner - 2005 - In Mitch Earleywine (ed.), Mind-Altering Drugs: The Science of Subjective Experience. Oxford University Press. pp. 25-48.
Malicious Pleasure Evaluated: Is Pleasure an Unconditional Good?Irwin Goldstein - 2003 - Pacific Philosophical Quarterly 84 (1):24–31.
Melding the Public and Private Spheres: Taking Commmensality Seriously.Albert O. Hirschman - 1996 - Critical Review: A Journal of Politics and Society 10 (4):533-550.
Addiction is Not an Affliction: Addictive Desires Are Merely Pleasure-Oriented Desires.Bennett Foddy & Julian Savulescu - 2007 - American Journal of Bioethics 7 (1):29 – 32.
Added to PP
Historical graph of downloads
Citations of this work
Greed, Gullibility, and Golden Eggs: FMT and Ethical, Legal, and Practical Difficulties Regulating Transactions in Readily Accessed and Exchanged Bodily Products.Robin Mackenzie - 2017 - American Journal of Bioethics 17 (5):57-59.
References found in this work
Towards a Functional Neuroanatomy of Pleasure and Happiness.Morten L. Kringelbach & Kent C. Berridge - 2009 - Trends in Cognitive Sciences 13 (11):479-487.
Human Feelings: Why Are Some More Aware Than Others?A. D. Craig - 2004 - Trends in Cognitive Sciences 8 (6):239-241.
Reason, Emotion and Decision-Making: Risk and Reward Computation with Feeling.Steven R. Quartz - 2009 - Trends in Cognitive Sciences 13 (5):209-215.
The Neurocircuitry of Impaired Insight in Drug Addiction.Rita Z. Goldstein, D. A., Antoine Bechara, Hugh Garavan, Anna Rose Childress, Martin P. Paulus & Nora D. Volkow - 2009 - Trends in Cognitive Sciences 13 (9):372.